Atricure Inc

Atricure Inc

ATRC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.89B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Atricure IncAtricure Inc188.9-3%4.70.2
$61.56

Target Price by Analysts

8.3% upsideAtricure Target Price DetailsTarget Price
$41.68

Current Fair Value

26.7% downside

Overvalued by 26.7% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.89 Billion
Enterprise Value$2.80 Billion
Earnings per Share$-0.24
Beta1.23
Outstanding Shares48,893,000

Return

Return on Equity2.79%ROE
Return on Assets2.07%
Return on Invested Capital1.61%

Valuation & Multiples

P/E Ratio188.9P/E Ratio
PEG-11.65PEG
Price to Sales4.74Price to Sales
Price to Book Ratio5.68Price to Book Ratio
Enterprise Value to Revenue4.75
Enterprise Value to EBIT274.07
Enterprise Value to Net Income188
Total Debt to Enterprise0.03
Debt to Equity0.17Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 4, 2026
EPS Estimate
-$0.04
Consensus analyst estimate
Revenue Estimate
$151.15 M
Consensus analyst estimate

Next Earnings Call

Expected Date
February 16, 2027
EPS Estimate
-$0.01
Consensus analyst estimate
Revenue Estimate
$159.44 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 1692.62%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %9.25%▼ 100.25%
Total Invested$251.87M▼ 83.02%
Investors Holding114▼ 148.00%

About Atricure Inc

Atricure Insider Information FAQ

Stockcircle tracks 6 top investors with a current 13F position in Atricure. Notable holders include Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions and 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 12 open-market insider sales for Atricure in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Stockcircle lists 3 politician trade disclosures tied to Atricure in the last twelve months, drawn from periodic financial disclosure reports. 1 politician traded Atricure in the past year.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.